BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, Albuquerque A, Allocca M, Esteve M, Farraye FA, Gordon H, Karmiris K, Kopylov U, Kirchgesner J, MacMahon E, Magro F, Maaser C, de Ridder L, Taxonera C, Toruner M, Tremblay L, Scharl M, Viget N, Zabana Y, Vavricka S. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis 2021;15:879-913. [PMID: 33730753 DOI: 10.1093/ecco-jcc/jjab052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferreiro-Iglesias R, Hernández-Camba A, Serrano Labajos R, Rodríguez-Lago I, Zabana Y, Barreiro-de Acosta M; Young Group of Geteccu, ACCU Spain. SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project. Gastroenterol Hepatol 2021:S0210-5705(21)00246-6. [PMID: 34453969 DOI: 10.1016/j.gastrohep.2021.08.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Le Cosquer G, Grangeon L, Rivière P, Berger A, Zerbib F, Laharie D, Poullenot F. A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease. Therap Adv Gastroenterol 2022;15:175628482210828. [DOI: 10.1177/17562848221082879] [Reference Citation Analysis]
3 Zacharopoulou E, Orfanoudaki E, Tzouvala M, Tribonias G, Kokkotis G, Kitsou V, Almpani F, Christidou A, Viazis N, Mantzaris GJ, Tsafaridou M, Karmiris K, Theodoropoulou A, Papathanasiou E, Zampeli E, Michopoulos S, Tigkas S, Michalopoulos G, Laoudi E, Karatzas P, Mylonas I, Kyriakos N, Liatsos C, Kafetzi T, Theocharis G, Taka S, Panagiotopoulou K, Koutroubakis IE, Bamias G. Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry. Inflamm Bowel Dis 2022:izac068. [PMID: 35394529 DOI: 10.1093/ibd/izac068] [Reference Citation Analysis]
4 Kim W, Lee B, Yoo A, Kim S, Joo M, Park JJ. Predictors of Positive Video Capsule Endoscopy Findings for Chronic Unexplained Abdominal Pain: Single-Center Retrospective Study and Meta-Analysis. Diagnostics (Basel) 2021;11:2123. [PMID: 34829470 DOI: 10.3390/diagnostics11112123] [Reference Citation Analysis]
5 Villaverde Piñeiro L, Cachafeiro Pin AI, Tajes González YM, Neira Blanco P, Arias Fernández L, Vázquez López M, Blanco Hortas A, Castro Rubiños C, Aparici Bolufer JV. Impact of a pharmaceutical intervention on influenza vaccination in patients receiving treatment with biological medicines. Eur J Hosp Pharm 2022:ejhpharm-2021-003175. [PMID: 35361619 DOI: 10.1136/ejhpharm-2021-003175] [Reference Citation Analysis]
6 Creemers RH, Rezazadeh Ardabili A, Jonkers DM, Leers MPG, Romberg-Camps MJ, Pierik MJ, van Bodegraven AA. Severe COVID-19 in inflammatory bowel disease patients in a population-based setting. PLoS One 2021;16:e0258271. [PMID: 34610041 DOI: 10.1371/journal.pone.0258271] [Reference Citation Analysis]
7 Macaluso FS, Liguori G, Galli M. Vaccinations in patients with inflammatory bowel disease. Dig Liver Dis 2021:S1590-8658(21)00267-X. [PMID: 34116972 DOI: 10.1016/j.dld.2021.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hashash JG, Farraye FA. Health Care Maintenance in Patients with Crohn's Disease. Gastroenterology Clinics of North America 2022. [DOI: 10.1016/j.gtc.2021.12.015] [Reference Citation Analysis]
9 Lee JY, Oh K, Hong HS, Kim K, Hong SW, Park JH, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Lee HS, Jo KW, Park SH. Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea. BMC Gastroenterol 2021;21:390. [PMID: 34670529 DOI: 10.1186/s12876-021-01973-5] [Reference Citation Analysis]
10 Yu N, Basnayake C, Connell W, Ding NS, Wright E, Stanley A, Fry S, Wilson-O'Brien A, Niewiadomski O, Lust M, Schulberg J, Kamm MA. Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review. Inflamm Bowel Dis 2021:izab247. [PMID: 34618007 DOI: 10.1093/ibd/izab247] [Reference Citation Analysis]
11 Kim YS. Does cytomegalovirus load predict the outcome of acute severe ulcerative colitis? Intest Res 2021;19:357-9. [PMID: 34731562 DOI: 10.5217/ir.2021.00120] [Reference Citation Analysis]
12 Jena A, Mishra S, Singh AK, Sekar A, Sharma V. Cytomegalovirus in ulcerative colitis: An evidence-based approach to diagnosis and treatment. Expert Review of Gastroenterology & Hepatology. [DOI: 10.1080/17474124.2022.2032662] [Reference Citation Analysis]
13 Peyrin-biroulet L, Siegmund B, Danese S, Hart A, Magro F, van der Woude J, Armuzzi A; ECCO Governing Board. Letter to the Editor. Journal of Crohn's and Colitis 2022. [DOI: 10.1093/ecco-jcc/jjab225] [Reference Citation Analysis]
14 Kim K, Jo KW, Shim TS, Park JH, Hwang SW, Park SH, Yang DH, Byeon JS, Myung SJ, Yang SK, Ye BD. Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors. Front Med (Lausanne) 2021;8:670242. [PMID: 34095175 DOI: 10.3389/fmed.2021.670242] [Reference Citation Analysis]
15 Lamberg T, Sipponen T, Valtanen S, Eklund KK, Mälkönen T, Aalto K, Mikola K, Kolho KL, Leinonen S, Isomäki P, Mäkinen H, Vidqvist KL, Kokko A, Huilaja L, Kyllönen M, Keskitalo P, Sard S, Vähäsalo P, Koskela R, Kröger L, Lahtinen P, Haapala AM, Korkatti K, Sokka-Isler T, Jokiranta TS; BLING Research Group. Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases. Autoimmunity 2022;:1-10. [PMID: 35481450 DOI: 10.1080/08916934.2022.2067985] [Reference Citation Analysis]
16 Costantino A, Noviello D, Conforti FS, Aloi M, Armuzzi A, Bossa F, Ficari F, Leone S, Manguso F, Mocci G, Orlando A, Pironi L, Radice S, Rizzello F, Tongiorgi A, Costantino C, Vecchi M, Caprioli F. COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association. Inflamm Bowel Dis 2021:izab172. [PMID: 34259844 DOI: 10.1093/ibd/izab172] [Reference Citation Analysis]
17 Bachmann J, Le Thi G, Brückner A, Kalteis AL, Schwerd T, Koletzko S, Lurz E. Epstein-Barr Virus Prevalence at Diagnosis and Seroconversion during Follow-Up in Pediatric Inflammatory Bowel Disease. J Clin Med 2021;10:5187. [PMID: 34768707 DOI: 10.3390/jcm10215187] [Reference Citation Analysis]
18 Kwon JY, Daoud ND, Hashash JG, Picco MF, Farraye FA. Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac079. [PMID: 35468183 DOI: 10.1093/ibd/izac079] [Reference Citation Analysis]
19 Khan N, Wang L, Trivedi C, Pernes T, Patel M, Xie D, Yang YX. Efficacy of Recombinant Zoster Vaccine in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00754-0. [PMID: 34274513 DOI: 10.1016/j.cgh.2021.07.023] [Reference Citation Analysis]
20 Flanagan E, Prentice R, Wright EK, Gibson PR, Ross AL, Begun J, Sparrow MP, Goldberg R, Rosella O, Burns M, Kiburg KV, Bell SJ. Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero. Aliment Pharmacol Ther 2021. [PMID: 34907546 DOI: 10.1111/apt.16739] [Reference Citation Analysis]